PT98202A - Processo para a preparacao de uma vacina contra a doenca de lyme, compreendendo uma quantidade dos principais antigenios contra b.burgdorferi - Google Patents
Processo para a preparacao de uma vacina contra a doenca de lyme, compreendendo uma quantidade dos principais antigenios contra b.burgdorferiInfo
- Publication number
- PT98202A PT98202A PT98202A PT9820291A PT98202A PT 98202 A PT98202 A PT 98202A PT 98202 A PT98202 A PT 98202A PT 9820291 A PT9820291 A PT 9820291A PT 98202 A PT98202 A PT 98202A
- Authority
- PT
- Portugal
- Prior art keywords
- burgdorferi
- osp
- lyme disease
- comprehensing
- mammal
- Prior art date
Links
- 241000589969 Borreliella burgdorferi Species 0.000 title abstract 5
- 208000016604 Lyme disease Diseases 0.000 title abstract 3
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 230000005540 biological transmission Effects 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54919090A | 1990-07-06 | 1990-07-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT98202A true PT98202A (pt) | 1992-05-29 |
| PT98202B PT98202B (pt) | 1999-02-26 |
Family
ID=24192007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98202A PT98202B (pt) | 1990-07-06 | 1991-07-04 | Processo para a preparacao de uma vacina contra a doenca de lyme, compreendendo uma quantidade dos principais antigenios contra b.burgdorferi |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP0465204B1 (pt) |
| JP (1) | JPH04297424A (pt) |
| AT (1) | ATE196425T1 (pt) |
| AU (1) | AU8014691A (pt) |
| CA (1) | CA2046025A1 (pt) |
| DE (1) | DE69132417T2 (pt) |
| DK (1) | DK0465204T3 (pt) |
| ES (1) | ES2149759T3 (pt) |
| GR (1) | GR3034460T3 (pt) |
| IE (2) | IE20010565A1 (pt) |
| PT (1) | PT98202B (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4015911A1 (de) * | 1989-09-19 | 1991-03-28 | Max Planck Gesellschaft | Impfstoff gegen die lyme-krankheit |
| US5217872A (en) * | 1990-02-27 | 1993-06-08 | The United States Of America As Represented By The Department Of Health And Human Services | Method for detection of borrelia burgdorferi antigens |
| CA2057536C (en) * | 1990-12-21 | 1999-10-26 | John J. Dunn | Cloning and expression of borrelia lipoproteins |
| US6221363B1 (en) * | 1991-07-11 | 2001-04-24 | Baxter Aktiengesellschaft | Vaccine for the prevention of lyme disease |
| DK0598816T3 (da) * | 1991-08-15 | 1999-11-22 | Deutsches Krebsforsch | Osp A-proteiner fra Borrelia Burgdorferi-undergrupper, hvilke proteiner koder for gener og vacciner |
| US6676942B1 (en) | 1991-08-15 | 2004-01-13 | Smithkline Beecham Biologicals (S.A.) | Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines |
| US7008625B2 (en) | 1993-11-01 | 2006-03-07 | Research Foundation Of The State University Of New York | Recombinant constructs of Borrelia burgdorferi |
| WO1995027504A1 (en) * | 1994-04-11 | 1995-10-19 | Solvay Animal Health, Inc. | Borrelia burgdorferi bacterin |
| DE19629543C2 (de) * | 1996-07-22 | 1999-02-11 | Immuno Ag | Immunassay zum Nachweis von anti-B. burgdorferi Antikörpern und Verfahren zur Serodiagnose bei Lyme Borreliose, diagnostische Mittel und Testkits zur Durchführung der Verfahren |
| US6368603B1 (en) * | 1997-03-05 | 2002-04-09 | Merial Limited | Lyme combination compositions and uses |
| US6660274B2 (en) * | 1997-06-30 | 2003-12-09 | The Administrators Of The Tulane Educational Fund | Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| US6475492B1 (en) * | 1999-04-28 | 2002-11-05 | The Administrators Of The Tulane Educational Fund | Peptides and assays for the diagnosis of lyme disease |
| EP1311540B1 (en) | 2000-08-18 | 2007-12-19 | Research Foundation Of State University Of New York | Altered ospa of borrelia burgdorferi |
| CN1835767A (zh) * | 2003-01-29 | 2006-09-20 | 辉瑞产品公司 | 对抗支气管败血性博德特氏杆菌的犬疫苗 |
| US20050202046A1 (en) * | 2004-03-11 | 2005-09-15 | Wyeth | Canine vaccine for protection against ehrlichiosis |
| US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| MX2009004866A (es) | 2006-11-03 | 2009-05-19 | Schering Plough Ltd | Vacuna para enfermedad de lyme canina. |
| ES2699812T3 (es) | 2012-02-01 | 2019-02-12 | Biopeptides Corp | Péptidos de diagnóstico para la enfermedad de Lyme |
| US10006912B2 (en) | 2013-12-06 | 2018-06-26 | Biopeptides Llc | Peptides for diagnosing lyme disease |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK590288D0 (da) * | 1988-10-24 | 1988-10-24 | Symbicom Ab | Kemiske forbindelser |
| US4372945A (en) | 1979-11-13 | 1983-02-08 | Likhite Vilas V | Antigen compounds |
| IL61904A (en) | 1981-01-13 | 1985-07-31 | Yeda Res & Dev | Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same |
| US4721617A (en) * | 1986-08-14 | 1988-01-26 | Regents Of The University Of Minnesota | Vaccine against lyme disease |
| DE4015911A1 (de) * | 1989-09-19 | 1991-03-28 | Max Planck Gesellschaft | Impfstoff gegen die lyme-krankheit |
| DE3942728C1 (en) * | 1989-12-22 | 1991-05-23 | Mikrogen Molekularbiologische Entwicklungs-Gmbh, 8000 Muenchen, De | New immunologically active proteins derived from Borelia burgdorferiensity polyethylene vessel and a high density polyethylene sealing cap - useful as vaccine and for quick accurate diagnosis of Borelia infections |
| WO1991013630A1 (en) * | 1990-03-05 | 1991-09-19 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | ANTIGENIC PROTEINS OF $i(BORRELIA BURGDORFERI) |
| WO1992000055A1 (en) * | 1990-06-15 | 1992-01-09 | Yale University | Compositions and methods for the prevention and diagnosis of lyme disease |
| DE59309159D1 (de) | 1992-08-21 | 1999-01-07 | Rolf Baechtiger | Kettengetriebe mit veränderlichem übersetzungsverhältnis und zahnkette |
-
1991
- 1991-07-01 DE DE69132417T patent/DE69132417T2/de not_active Expired - Fee Related
- 1991-07-01 AT AT91305971T patent/ATE196425T1/de not_active IP Right Cessation
- 1991-07-01 IE IE20010565A patent/IE20010565A1/en not_active IP Right Cessation
- 1991-07-01 IE IE230391A patent/IE912303A1/en not_active IP Right Cessation
- 1991-07-01 EP EP91305971A patent/EP0465204B1/en not_active Expired - Lifetime
- 1991-07-01 ES ES91305971T patent/ES2149759T3/es not_active Expired - Lifetime
- 1991-07-01 DK DK91305971T patent/DK0465204T3/da active
- 1991-07-01 EP EP99125481A patent/EP1016416A3/en not_active Withdrawn
- 1991-07-02 AU AU80146/91A patent/AU8014691A/en not_active Abandoned
- 1991-07-02 CA CA002046025A patent/CA2046025A1/en not_active Abandoned
- 1991-07-04 PT PT98202A patent/PT98202B/pt not_active IP Right Cessation
- 1991-07-04 JP JP3164264A patent/JPH04297424A/ja active Pending
-
2000
- 2000-09-21 GR GR20000402129T patent/GR3034460T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU8014691A (en) | 1992-01-09 |
| EP1016416A3 (en) | 2002-10-23 |
| EP0465204B1 (en) | 2000-09-20 |
| ES2149759T3 (es) | 2000-11-16 |
| EP0465204A2 (en) | 1992-01-08 |
| JPH04297424A (ja) | 1992-10-21 |
| DK0465204T3 (da) | 2000-10-09 |
| ATE196425T1 (de) | 2000-10-15 |
| IE912303A1 (en) | 1992-01-15 |
| EP1016416A2 (en) | 2000-07-05 |
| EP0465204A3 (en) | 1993-03-10 |
| GR3034460T3 (en) | 2000-12-29 |
| CA2046025A1 (en) | 1992-01-07 |
| DE69132417T2 (de) | 2001-05-23 |
| DE69132417D1 (de) | 2000-10-26 |
| PT98202B (pt) | 1999-02-26 |
| IE20010565A1 (en) | 2002-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT98202A (pt) | Processo para a preparacao de uma vacina contra a doenca de lyme, compreendendo uma quantidade dos principais antigenios contra b.burgdorferi | |
| NO176004C (no) | Fremgangsmåte ved fremstilling av vaksine mot hunde-coronavirus | |
| ATE200735T1 (de) | Impfstoffkonjugat | |
| DE3071594D1 (en) | Feline infectious peritonitis virus, its preparation and vaccines containing it | |
| US4400472A (en) | Novel rabies virus strain and a process for its preparation | |
| ATE102650T1 (de) | Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung. | |
| US3709782A (en) | Heteroploid cell lines | |
| ES8105930A1 (es) | Procedimiento para la preparacion de vacunas de virus poli- valentes | |
| DK0626008T3 (da) | Vaccine, der som en adjuvans indeholder acemannan | |
| ATE31116T1 (de) | Diagnostisches antigen fuer traeger der durch pseudorabiesviren verursachten krankheit bei schweinen. | |
| McFerran et al. | Comparative studies with inactivated and attenuated vaccines for protection of fattening pigs | |
| NZ226353A (en) | Feline infectious peritonitus (fip) vaccine | |
| ATE39055T1 (de) | Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit. | |
| KR920007636A (ko) | 신규의 백신체 | |
| JPH07561B2 (ja) | 牛アデノウイルス７型ワクチン | |
| Wisniewski et al. | Effect of passive immunity of calves, acquired by colostrum, on the results of vaccination against foot-and-mouth disease | |
| Zourbas et al. | Immunization of dental surgeons against hepatitis B virus infection. | |
| UA65803A (en) | Associated intradermal vaccine against techin's disease and aujeski's disease | |
| GB2052983A (en) | Vaccine for infectious bovine rhinotracheitis | |
| NL8005083A (nl) | Infectieuze bronchitis vaccins voor pluimvee en werkwijze voor het bereiden van dergelijke vaccins. | |
| RU95104923A (ru) | Штамм вируса герпеса кур "42" - деп для изготовления вакцины против болезни марека |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19920214 |
|
| FG3A | Patent granted, date of granting |
Effective date: 19981111 |
|
| PC3A | Transfer or assignment |
Free format text: WYETH US Effective date: 20030123 |
|
| MM3A | Annulment or lapse |
Effective date: 20060511 |